Between 2015 and 2017, two pharmacy technicians at a Chicago pharmacy stole more than 56,000 hydrocodone pills and sold them for profit. One technician concealed the thefts by falsifying the pharmacy's inventory so the pills appeared not to have been received from the distributor or to have been dispensed to patients. Both technicians pleaded guilty to federal drug charges and were sentenced in 2019 to prison terms of five years and one year.
A DEA inspection and audit found that the pharmacy failed to keep adequate records of the receipt and disposition of controlled substances, including hydrocodone-acetaminophen and alprazolam, and failed to provide effective controls and procedures to prevent theft and diversion.
In September 2025 the U.S. Attorney's Office for the Northern District of Illinois announced a civil settlement resolving alleged Controlled Substances Act violations. The pharmacy agreed to pay a $250,000 penalty. News coverage of the announcement noted the pharmacy had also completed obligations under a memorandum of agreement with DEA requiring complete and accurate controlled-substance recordkeeping, and that the settlement was not an admission of liability.